{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:21:56Z","timestamp":1745554916711,"version":"3.40.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,24]]},"DOI":"10.7759\/cureus.82924","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T17:27:23Z","timestamp":1745515643000},"source":"Crossref","is-referenced-by-count":0,"title":["From Mood to Memory: Unlocking Saffron\u2019s Potential in Brain Health"],"prefix":"10.7759","author":[{"given":"Tarlan","family":"Kehtari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Cardenas","family":"Tovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dustin","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Junquera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148423","article-title":"Putative pathological mechanisms of late-life depression and Alzheimer's disease","volume":"1813","author":"Hasan SM","year":"2023","unstructured":"Hasan SM, Clarke C, Strand T, Bambico FR. Putative pathological mechanisms of late-life depression and Alzheimer's disease. Brain Res. 2023, 1813:148423. 10.1016\/j.brainres.2023.148423","journal-title":"Brain Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.01.012","article-title":"Development of apathy, anxiety, and depression in cognitively unimpaired older adults: effects of Alzheimer's disease pathology and cognitive decline","volume":"92","author":"Johansson M","year":"2022","unstructured":"Johansson M, Stomrud E, Johansson PM, et al..  Development of apathy, anxiety, and depression in cognitively unimpaired older adults: effects of Alzheimer's disease pathology and cognitive decline. Biol Psychiatry. 2022, 92:34-43. 10.1016\/j.biopsych.2022.01.012","journal-title":"Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17040442","article-title":"Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults","volume":"175","author":"Donovan NJ","year":"2018","unstructured":"Donovan NJ, Locascio JJ, Marshall GA, et al.. Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry. 2018, 175:530-7. 10.1176\/appi.ajp.2017.17040442","journal-title":"Am J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.2476","article-title":"Amyloid-\u03b2, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study","volume":"72","author":"Pietrzak RH","year":"2015","unstructured":"Pietrzak RH, Lim YY, Neumeister A, et al.. Amyloid-\u03b2, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. JAMA Psychiatry. 2015, 72:284-91. 10.1001\/jamapsychiatry.2014.2476","journal-title":"JAMA Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00034","article-title":"Depressive symptoms in the elderly-an early symptom of dementia? A systematic review","volume":"11","author":"Wiels W","year":"2020","unstructured":"Wiels W, Baeken C, Engelborghs S. Depressive symptoms in the elderly-an early symptom of dementia? A systematic review. Front Pharmacol. 2020, 11:34. 10.3389\/fphar.2020.00034","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2020.1857682","article-title":"Nutritional and health beneficial properties of saffron (Crocus sativus L): a comprehensive review","volume":"62","author":"Abu-Izneid T","year":"2022","unstructured":"Abu-Izneid T, Rauf A, Khalil AA, et al.. Nutritional and health beneficial properties of saffron (Crocus sativus L): a comprehensive review. Crit Rev Food Sci Nutr. 2022, 62:2683-706. 10.1080\/10408398.2020.1857682","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000001118","article-title":"Safety and efficacy of saffron (Crocus sativus L.) for treating mild to moderate depression: a systematic review and meta-analysis","volume":"208","author":"Dai L","year":"2020","unstructured":"Dai L, Chen L, Wang W. Safety and efficacy of saffron (Crocus sativus L.) for treating mild to moderate depression: a systematic review and meta-analysis. J Nerv Ment Dis. 2020, 208:269-76. 10.1097\/NMD.0000000000001118","journal-title":"J Nerv Ment Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.11.020","article-title":"Saffron in the treatment of depression, anxiety and other mental disorders: current evidence and potential mechanisms of action","volume":"227","author":"Shafiee M","year":"2018","unstructured":"Shafiee M, Arekhi S, Omranzadeh A, Sahebkar A. Saffron in the treatment of depression, anxiety and other mental disorders: current evidence and potential mechanisms of action. J Affect Disord. 2018, 227:330-7. 10.1016\/j.jad.2017.11.020","journal-title":"J Affect Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2006.08.006","article-title":"Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial","volume":"13","author":"Moshiri E","year":"2006","unstructured":"Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006, 13:607-11. 10.1016\/j.phymed.2006.08.006","journal-title":"Phytomedicine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.11.035","article-title":"Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial","volume":"174","author":"Talaei A","year":"2015","unstructured":"Talaei A, Hassanpour Moghadam M, Sajadi Tabassi SA, Mohajeri SA. Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial. J Affect Disord. 2015, 174:51-6. 10.1016\/j.jad.2014.11.035","journal-title":"J Affect Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.11.003","article-title":"A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients","volume":"155","author":"Shahmansouri N","year":"2014","unstructured":"Shahmansouri N, Farokhnia M, Abbasi SH, et al.. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. J Affect Disord. 2014, 155:216-22. 10.1016\/j.jad.2013.11.003","journal-title":"J Affect Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.1647","article-title":"Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial","volume":"19","author":"Akhondzadeh S","year":"2005","unstructured":"Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, Amini H, Fallah-Pour H, Jamshidi AH, Khani M. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res. 2005, 19:148-51. 10.1002\/ptr.1647","journal-title":"Phytother Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2004.11.004","article-title":"Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial","volume":"97","author":"Noorbala AA","year":"2005","unstructured":"Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol. 2005, 97:281-4. 10.1016\/j.jep.2004.11.004","journal-title":"J Ethnopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01133.x","article-title":"Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial","volume":"35","author":"Akhondzadeh S","year":"2010","unstructured":"Akhondzadeh S, Sabet MS, Harirchian MH, et al.. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther. 2010, 35:581-8. 10.1111\/j.1365-2710.2009.01133.x","journal-title":"J Clin Pharm Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1706-1","article-title":"A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease","volume":"207","author":"Akhondzadeh S","year":"2010","unstructured":"Akhondzadeh S, Shafiee Sabet M, Harirchian MH, et al.. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology (Berl). 2010, 207:637-43. 10.1007\/s00213-009-1706-1","journal-title":"Psychopharmacology (Berl)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2412","article-title":"Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial","volume":"29","author":"Farokhnia M","year":"2014","unstructured":"Farokhnia M, Shafiee Sabet M, Iranpour N, et al.. Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial. Hum Psychopharmacol. 2014, 29:351-9. 10.1002\/hup.2412","journal-title":"Hum Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-020-03102-3","article-title":"Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials","volume":"20","author":"Ayati Z","year":"2020","unstructured":"Ayati Z, Yang G, Ayati MH, Emami SA, Chang D. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complement Med Ther. 2020, 20:333. 10.1186\/s12906-020-03102-3","journal-title":"BMC Complement Med Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1021\/jf300589c","article-title":"Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies","volume":"60","author":"Geromichalos GD","year":"2012","unstructured":"Geromichalos GD, Lamari FN, Papandreou MA, Trafalis DT, Margarity M, Papageorgiou A, Sinakos Z. Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies. J Agric Food Chem. 2012, 60:6131-8. 10.1021\/jf300589c","journal-title":"J Agric Food Chem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2020.1864279","article-title":"Saffron bioactives crocin, crocetin and safranal: effect on oxidative stress and mechanisms of action","volume":"62","author":"Cerd\u00e1-Bernad D","year":"2022","unstructured":"Cerd\u00e1-Bernad D, Valero-Cases E, Pastor JJ, Frutos MJ. Saffron bioactives crocin, crocetin and safranal: effect on oxidative stress and mechanisms of action. Crit Rev Food Sci Nutr. 2022, 62:3232-49. 10.1080\/10408398.2020.1864279","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110713","article-title":"Crocin ameliorates arsenic trioxide\u2011induced cardiotoxicity via Keap1-Nrf2\/HO-1 pathway: reducing oxidative stress, inflammation, and apoptosis","volume":"131","author":"Liang Y","year":"2020","unstructured":"Liang Y, Zheng B, Li J, et al.. Crocin ameliorates arsenic trioxide\u2011induced cardiotoxicity via Keap1-Nrf2\/HO-1 pathway: reducing oxidative stress, inflammation, and apoptosis. Biomed Pharmacother. 2020, 131:110713. 10.1016\/j.biopha.2020.110713","journal-title":"Biomed Pharmacother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/tox.24216","article-title":"Protective effect of crocin on peroxidation-induced oxidative stress and apoptosis in IPEC-J2 cells","volume":"39","author":"Wang J","year":"2024","unstructured":"Wang J, Song H, Huang Y, et al.. Protective effect of crocin on peroxidation-induced oxidative stress and apoptosis in IPEC-J2 cells. Environ Toxicol. 2024, 39:3537-47. 10.1002\/tox.24216","journal-title":"Environ Toxicol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109305","article-title":"The effects of crocetin on oxidative stress induced ARPE-19 cells by H(2)O(2)","volume":"226","author":"Demirci Kucuk K","year":"2023","unstructured":"Demirci Kucuk K, Tokuc EO, Aciksari A, Duruksu G, Yazir Y, Karabas VL. The effects of crocetin on oxidative stress induced ARPE-19 cells by H(2)O(2). Exp Eye Res. 2023, 226:109305. 10.1016\/j.exer.2022.109305","journal-title":"Exp Eye Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2013.06.056","article-title":"Saucerneol F inhibits tumor necrosis factor-\u03b1 and IL-6 production by suppressing Fyn-mediated pathways in Fc\u03b5RI-mediated mast cells","volume":"59","author":"Lu Y","year":"2013","unstructured":"Lu Y, Piao D, Zhang H, et al.. Saucerneol F inhibits tumor necrosis factor-\u03b1 and IL-6 production by suppressing Fyn-mediated pathways in Fc\u03b5RI-mediated mast cells. Food Chem Toxicol. 2013, 59:696-702. 10.1016\/j.fct.2013.06.056","journal-title":"Food Chem Toxicol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07163-3","article-title":"Protective effect of saffron in mouse colitis models through immune modulation","volume":"67","author":"Singh G","year":"2022","unstructured":"Singh G, Haileselassie Y, Ji AR, et al.. Protective effect of saffron in mouse colitis models through immune modulation. Dig Dis Sci. 2022, 67:2922-35. 10.1007\/s10620-021-07163-3","journal-title":"Dig Dis Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115582","article-title":"Safranal inhibits NLRP3 inflammasome activation by preventing ASC oligomerization","volume":"423","author":"Gupta M","year":"2021","unstructured":"Gupta M, Wani A, Ahsan AU, et al.. Safranal inhibits NLRP3 inflammasome activation by preventing ASC oligomerization. Toxicol Appl Pharmacol. 2021, 423:115582. 10.1016\/j.taap.2021.115582","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111739","article-title":"Therapeutic potentials of crocin in medication of neurological disorders","volume":"145","author":"Ahmed S","year":"2020","unstructured":"Ahmed S, Hasan MM, Heydari M, et al.. Therapeutic potentials of crocin in medication of neurological disorders. Food Chem Toxicol. 2020, 145:111739. 10.1016\/j.fct.2020.111739","journal-title":"Food Chem Toxicol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.01.017","article-title":"Crocin may be useful to prevent or treatment of alcohol induced neurodegeneration and neurobehavioral sequels via modulation of CREB\/BDNF and Akt\/GSK signaling pathway","volume":"124","author":"Motaghinejad M","year":"2019","unstructured":"Motaghinejad M, Safari S, Feizipour S, Sadr S. Crocin may be useful to prevent or treatment of alcohol induced neurodegeneration and neurobehavioral sequels via modulation of CREB\/BDNF and Akt\/GSK signaling pathway. Med Hypotheses. 2019, 124:21-5. 10.1016\/j.mehy.2019.01.017","journal-title":"Med Hypotheses"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2020.152209","article-title":"Crocin alleviates schizophrenia-like symptoms in rats by upregulating silent information regulator-1 and brain derived neurotrophic factor","volume":"103","author":"Sun XJ","year":"2020","unstructured":"Sun XJ, Zhao X, Xie JN, Wan H. Crocin alleviates schizophrenia-like symptoms in rats by upregulating silent information regulator-1 and brain derived neurotrophic factor. Compr Psychiatry. 2020, 103:152209. 10.1016\/j.comppsych.2020.152209","journal-title":"Compr Psychiatry"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203132","article-title":"Crocetin regulates functions of neural stem cells to generate new neurons for cerebral ischemia recovery","volume":"12","author":"Liu Z","year":"2023","unstructured":"Liu Z, Wang Z, Zhu Z, et al.. Crocetin regulates functions of neural stem cells to generate new neurons for cerebral ischemia recovery. Adv Healthc Mater. 2023, 12:e2203132. 10.1002\/adhm.202203132","journal-title":"Adv Healthc Mater"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/356774-from-mood-to-memory-unlocking-saffrons-potential-in-brain-health","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T17:27:24Z","timestamp":1745515644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/356774-from-mood-to-memory-unlocking-saffrons-potential-in-brain-health"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.82924","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}